Elago, Baby Girl .

HRN: 23-45-61  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/31/2023
09/07/2023
IVTT
46mg
Q24
PSNB
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: